Mora, Ana L.
Rojas, Mauricio
Pardo, Annie
Selman, Moises
Article History
First Online: 6 October 2017
Change Date: 30 October 2017
Change Type: Correction
Change Details: In the original version, navitoclax was incorrectly referred to as an apoptosis inhibitor in Figure 3. The error has been corrected online.
Competing interests
: M.S. contributes to the Adjudication Committee in a clinical trial on idiopathic pulmonary fibrosis conducted by Celgene. M.R., A.P. and A.L.M. declare no competing interests.